ObjectiveTo investigate the relation ship of obesity with high blood pressure and type 2 diabetes and to find characteristics of the prevalence. MethodsFrom different BMI groups,2,090 cases aged 60-86 years were randomly collected according to the medical and health information.Hypertension and diabetes were diagnosed by WHO international diagnostic criteria.ResultsIn hypertension group (976 cases), average body mass index (BMI), pulse pressure ( PP), total cholesterol (TC), triglyceride (TG), fasting blood glucose (FBG) showed significant difference compared with non-hypertention group (1114 cases) (all P＜0.01)[(26.32±3.66)kg/m2 , (16.28±13.21 )mm Hg, (4.78±1.23) mmol/L, (1.79±1.36) mmol/L, (5.61±1.37) mmol/L vs. (25.28± 3.36) kg/m2, ( 11.37 ± 9.39) mm Hg, (4.54 ± 1.23 ) mmol/L, ( 1.52 ± 1.12) mmol/L, ( 4.28 ±2.12)mmol/L].In diabetes group (272 cases), average BMI, PP, TC, TG and FBG showed significant difference as compared with non-diabetes group (1818 cases)(all P＜0.01)[(26. 29±3.24)kg/m2 , (82.43± 10.22) mm Hg, (18.77±10.11) mm Hg, (4.85±2.05) mmol/L, (1.76± 1.76)mmol/L vs. (24.13±3.42) kg/m2 , (80.38±6.87) mm Hg, (12.26±9.56) mm Hg, (4.36± 1.21)mmol/L, (1.52± 1.21) mmol/L]. In normal blood lipids group, BMI, PP, and FBG were found significant differences compared with high TC or TG group (all P＜0.05).ConclusionsThe increase of body mass index in the elderly has a close relationship with hypertension and type 2 diabetes. It is important to prevent obesity in the prevention and control of hypertension and diabetes.

Objective:To compare the clinical outcomes of endovascular therapy in acute stroke patients with anterior circulation tandem occlusions caused by atherosclerosis or dissection.Methods:A retrospective cohort study. A total of 98 patients with anterior circulation tandem lesions undergoing endovascular therapy in the Wuhan NO.1 Hospital (March 2016 to March 2022) were analyzed. Median age was 64(55,71) years old, and 82.7% (81/98 cases) were males. According to the lesion etiology, the patients were divided into atherosclerosis and dissection groups. The differences in clinical outcomes between the two groups were investigated, including favorable 90-day functional outcome (modified Rankin Scale score of 0-2), successful reperfusion (modified Thrombolysis in Cerebrovascular Infarction score of 2b-3), symptomatic intracranial hemorrhage, stroke-associated pneumonia, 90-day all-cause mortality, and average hospitalization days. Logistic regression analysis was used to adjust for potential confounders affecting functional outcomes in both groups, and to determine odds ratios and 95% confidence intervals.Results:Seventy-one patients were grouped into the atherosclerotic cause and 27 into the dissection cause cohorts. The rate of favorable 90-day functional outcome was 43.7% (31/71 cases) in the atherosclerosis group versus 55.6% (15/27 cases) in the dissection group (adjusted odds ratio=1.339; 95% confidence interval, 0.374-4.798; P=0.654). No significant differences were found in other clinical outcomes between the two groups (all P>0.05). Conclusion:The clinical prognosis of patients with tandem lesions caused by atherosclerotic stenosis or artery dissection was similar after endovascular therapy. Future studies are still needed to verify our results.

BACKGROUND: Perioperative treatment has become an increasingly important aspect of the management of patients with non-small cell lung cancer (NSCLC). Small-scale clinical studies performed in recent years have shown improvements in the major pathological remission rate after neoadjuvant therapy, suggesting that it will soon become an important part of NSCLC treatment. Nevertheless, neoadjuvant immunotherapy may be accompanied by serious adverse reactions that lead to delay or cancelation of surgery, additional illness, and even death, and have therefore attracted much attention. The purpose of the clinical recommendations is to form a diagnosis and treatment plan suitable for the current domestic medical situation for the immune-related adverse event (irAE). METHODS: This recommendation is composed of experts in thoracic surgery, oncologists, thoracic medicine and irAE related departments (gastroenterology, respirology, cardiology, infectious medicine, hematology, endocrinology, rheumatology, neurology, dermatology, emergency section) to jointly complete the formulation. Experts make full reference to the irAE guidelines, large-scale clinical research data published by thoracic surgery, and the clinical experience of domestic doctors and publicly published cases, and repeated discussions in multiple disciplines to form this recommendation for perioperative irAE. RESULTS: This clinical recommendation covers the whole process of prevention, evaluation, examination, treatment and monitoring related to irAE, so as to guide the clinical work comprehensively and effectively. CONCLUSIONS Perioperative irAE management is an important part of immune perioperative treatment of lung cancer. With the continuous development of immune perioperative treatment, more research is needed in the future to optimize the diagnosis and treatment of perioperative irAE.